Prepare a U.S. biotech organization for product launch in 18 months.

Define launch planning and management process for global medical affairs team anticipating 20+ launches.

To develop a comprehensive commercial roadmap for the life of an asset, including key activities and their timing, ownership and budget constraints.

Client field force was conducting patient directed product and disease state education and was seeking a way to increase engagement with target healthcare providers.

Existing payer value proposition framework was not establishing competitive advantage and the AE presentation powerpoint was cumbersome and therefore under-utilized.

Mid-sized pharmaceutical client had an increase in portfolio size and was seeking to develop a comprehensive process for stage gate decisions and role/responsibilities alignment across global and affiliate teams.